AI-assisted decision support for sickle cell disease severity stratification using routine blood tests: a systematic review and meta-analysis.
Simple blood tests combined with AI can help identify sickle cell disease severity in resource-limited settings, enabling earlier intervention and better care planning.
This systematic review and meta-analysis synthesized AI/ML evidence for SCD severity stratification using routine blood tests, addressing the unmet need for accessible risk tools in resource-limited settings. Pooled findings support CBC-based AI as a practical, low-cost decision support adjunct for SCD severity assessment.
What the study was
- Study design
- Systematic review and meta-analysis
- Category
- Other
- Maturity
- Validated
- Journal
- BMC Med Inform Decis Mak
Why it surfaced
Directly relevant to T2 CBC-ML topic; systematic review + meta-analysis provides highest evidence level; SCD is a high-unmet-need rare hematologic disease; validates routine CBC as AI input for clinical decision support.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.